Are you a little bit country? Or a little bit rock n’ roll? Either way, if you have diabetes, you’ll no doubt find inspiration in George Canyon, the Canadian country singer who rocketed to fame as a runner-up in the 2004 Nashville Star 2 reality TV competition. Since then, he’s had two subsequent blockbuster albums — One Good Friend, and Somebody Wrote Love — and become a huge public proponent for JDRF, traveling the US, Canada,…Read more »
Many of us patient advocates who make the rounds at e-patient and health 2.0 conferences hear an awful lot of talk about “what the patient wants” and how Pharma and device companies should reach out to our communities online. Meanwhile, they’ve been slow to embrace Social Media, and given the controversy over FDA regulations for this, who knows what’s happening internally at these companies as they struggle to form a viable strategy for getting involved?…Read more »
I could call today’s guest post a “straggler” from my Summer Reading series, but that might downplay its impact. Good things take time, as noted today by Samantha Katz, who along with a fellow graduate student at Northwestern University, won the the $10K Grand Prize in the 2009 DiabetesMine Design Challenge.
She was subsequently hired by Medtronic as a Global Product Manager for their evolving insulin pump systems (! – and she served as a…
When the JDRF recently announced its newest artificial pancreas push — a partnership with Animas and Dexcom to actually develop a commercial product — head of the project Aaron Kowalski kindly agreed to answer reader questions here.
Today, I bring you those answers, direct “from the horses’ mouth,” as it were.
Q) How much more advanced will this be than the Medtronic Paradigm Veo system launched in Europe, which stops insulin delivery for…
Very big news in the diabetes world today, Folks: the Juvenile Diabetes Research Foundation (JDRF) has announced a partnership with insulin pump makers Animas Corp. (a Johnson & Johnson company) to actually start building the first ready-for-market artificial pancreas, i.e. “a fully automated system to dispense insulin … based on real-time changes in blood sugar levels.” DexCom will provide the continuous glucose monitoring (CGM) technology for the new system being developed.
I was fortunate to…